Digital Pharmaceutics and Pharmaceutical Industry 4.0: Transforming Drug Formulation and Manufacturing through Digital Technologies
DOI:
https://doi.org/10.64882/ijrt.v11.i2.1794Keywords:
Digital Pharmaceutics, Pharmaceutical Industry 4.0, Artificial Intelligence, Smart Manufacturing, Machine LearningAbstract
Digital transformation is rapidly reshaping pharmaceutical research, formulation development and manufacturing through the integration of advanced digital technologies under the emerging paradigm of Digital Pharmaceutics and Pharmaceutical Industry 4.0. Traditional pharmaceutical development relies extensively on experimental approaches, which may require substantial time, resources and iterative optimisation. Digital technologies, including artificial intelligence, machine learning, Internet of Things, big data analytics, cloud computing, digital twins, robotics and process automation, offer opportunities to improve formulation design, process understanding, quality control and manufacturing efficiency. Artificial intelligence and machine learning can facilitate prediction of drug–excipient interactions, formulation performance, dissolution behaviour and critical quality attributes, thereby supporting data-driven formulation optimisation. The integration of Quality by Design and Process Analytical Technology with digital systems enables real-time monitoring, predictive process control and improved product consistency. Digital twins and connected manufacturing platforms further support simulation, process optimisation, predictive maintenance and continuous manufacturing. Despite these advantages, implementation remains associated with challenges involving data integrity, cybersecurity, interoperability, regulatory validation, infrastructure investment and workforce competencies. This review critically examines the role of digital technologies in modern pharmaceutical formulation and manufacturing, with particular emphasis on artificial intelligence, machine learning, IoT, big data, digital twins, QbD, PAT and continuous manufacturing. The review also discusses current applications, benefits, limitations, regulatory considerations and future prospects for developing intelligent, connected and patient-centric pharmaceutical manufacturing systems.
References
Arden, N. S., Fisher, A. C., Tyner, K., Yu, L. X., Lee, S. L., & Kopcha, M. (2021). Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future. International Journal of Pharmaceutics, 602, 120554.
Bannigan, P., Aldeghi, M., Bao, Z., Häse, F., Aspuru-Guzik, A., & Allen, C. (2021). Machine learning directed drug formulation development. Advanced Drug Delivery Reviews, 175, 113806.
Barenji, R. V., Akdag, Y., Yet, B., & Oner, L. (2022). Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0. International Journal of Pharmaceutics, 567, 118658.
Chen, Y., Yang, O., Sampat, C., Bhalode, P., Ramachandran, R., & Ierapetritou, M. (2020). Digital twins in pharmaceutical and biopharmaceutical manufacturing: A literature review. Processes, 8(9), 1088.
Ding, B. (2018). Pharma industry 4.0: Literature review and research opportunities in sustainable pharmaceutical supply chains. Process Safety and Environmental Protection, 119, 115–130.
Fonteyne, M., Vercruysse, J., De Leersnyder, F., Van Snick, B., Vervaet, C., Remon, J. P., & De Beer, T. (2015). Process analytical technology for continuous manufacturing of solid-dosage forms. TrAC Trends in Analytical Chemistry, 67, 159–166.
Han, R., Xiong, H., Ye, Z., Yang, Y., Huang, T., Jing, Q., Lu, J., Pan, H., Ren, F., & Ouyang, D. (2019). Predicting physical stability of solid dispersions by machine learning techniques. Journal of Controlled Release, 311–312, 16–25.
Lee, S. L., O'Connor, T. F., Yang, X., Cruz, C. N., Chatterjee, S., Madurawe, R. D., Moore, C. M. V., Yu, L. X., & Woodcock, J. (2015). Modernizing pharmaceutical manufacturing: From batch to continuous production. Journal of Pharmaceutical Innovation, 10(3), 191–199.
Mak, K. K., & Pichika, M. R. (2019). Artificial intelligence in drug development: Present status and future prospects. Drug Discovery Today, 24(3), 773–780.
Nasr, M. M., Krumme, M., Matsuda, Y., Trout, B. L., Badman, C., Mascia, S., Cooney, C. L., Jensen, K. D., Florence, A., Johnston, C., Konstantinov, K., & Lee, S. L. (2017). Regulatory perspectives on continuous pharmaceutical manufacturing: Moving from theory to practice. Journal of Pharmaceutical Sciences, 106(11), 3199–3206.
Ouyang, D., Zhang, W., Maleki Dizaj, S., & Adibkia, K. (2022). Artificial intelligence for pharmaceutical sciences: Bridging computation and experiment. Pharmaceutics, 14(11), 2432.
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021). Artificial intelligence in drug discovery and development. Drug Discovery Today, 26(1), 80–93.
Rantanen, J., & Khinast, J. (2015). The future of pharmaceutical manufacturing sciences. Journal of Pharmaceutical Sciences, 104(11), 3612–3638.
Reinhardt, I. C., Oliveira, J. C., & Ring, D. T. (2020). Current perspectives on the development of industry 4.0 in the pharmaceutical sector. Journal of Industrial Information Integration, 18, 100131.
Silva, C. J., Barros, M. R., Marques, F., Peixoto, C., Nunes, A., Aires-Barros, M. R., Serra, M., & Silva, R. J. S. (2022). Digitalization in pharmaceutical industry: What to focus on under the digital implementation process? International Journal of Pharmaceutics X, 4, 100131.
Simon, L. L., Pataki, H., Marosi, G., Meemken, F., Hungerbühler, K., Baiker, A., Tummala, S., Glennon, B., Kuentz, M., Steele, G., Kramer, H. J. M., Rydzak, J. W., Chen, Z., Morris, J., Kjell, F., Singh, R., Gani, R., Gernaey, K. V., … Chiu, M.-S. (2015). Assessment of recent process analytical technology (PAT) trends: A multiauthor review. Organic Process Research & Development, 19(1), 3–62.
Su, Q., Ganesh, S., Moreno, M., Bommireddy, Y., Gonzalez, M., Reklaitis, G. V., & Nagy, Z. K. (2019). A perspective on Quality-by-Control (QbC) in pharmaceutical continuous manufacturing. Computers & Chemical Engineering, 125, 216–231.
Udugama, I. A., Lopez, P. C., Gargalo, C. L., Li, X., Bayer, C., & Gernaey, K. V. (2021). Digital twin in biomanufacturing: Challenges and opportunities towards its implementation. Systems Microbiology and Biomanufacturing, 1(3), 257–274.
U.S. Food and Drug Administration. (2004). Guidance for industry: PAT — A framework for innovative pharmaceutical development, manufacturing, and quality assurance. FDA. [Foundational regulatory document underpinning the 2013–2022 PAT and digital-pharmaceutics literature]
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., & Zhao, S. (2019). Applications of machine learning in drug discovery and development. Nature Reviews Drug Discovery, 18(6), 463–477.
Wang, S., Di, J., Wang, D., Dai, X., Hua, Y., Gao, X., Zheng, A., & Gao, J. (2022). State-of-the-art review of artificial neural networks to predict, characterize and optimize pharmaceutical formulation. Pharmaceutics, 14(1), 183.
Yang, Y., Ye, Z., Su, Y., Zhao, Q., Li, X., & Ouyang, D. (2019). Deep learning for in vitro prediction of pharmaceutical formulations. Acta Pharmaceutica Sinica B, 9(1), 177–185.
Yu, L. X., Amidon, G., Khan, M. A., Hoag, S. W., Polli, J., Raju, G. K., & Woodcock, J. (2014). Understanding pharmaceutical quality by design. The AAPS Journal, 16(4), 771–783.
Zheng, Y., Wu, Y., Zhou, Y., Wang, X., Jiang, R., Zhang, Q., & Wang, W. (2020). Machine learning modeling and predictive control of the batch crystallization process. Industrial & Engineering Chemistry Research, 59(45), 20155–20166.
Steinwandter, V., Borchert, D., & Herwig, C. (2019). Data science tools and applications on the way to Pharma 4.0. Drug Discovery Today, 24(9), 1795–1805.
Downloads
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
